Release Date: 29/04/11 13:24 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 26.03KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%